• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Lucidenic acid B Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5760599

Lucidenic acid B shows antioxidative, and anti-invasive effects, it inhibits PMA-induced invasion of human hepatoma cells through inactivating MAPK/ERK signal transduction pathway and reducing binding activities of NF-kappaB and AP-1. Lucidenic acid B also… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Lucidenic acid B, Inhibitor
Full Product Name
Lucidenic acid B
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
474.59
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C27H38O7
SMILES
C[C@H](CCC(O)=O)[C@@H](CC1=O)[C@@](C)([C@@H]2O)[C@]1(C)C([C@H](C[C@@H](C1(C)C)[C@]3(C)CCC1=O)O)=C3C2=O
CAS Number
95311-95-8
Target & IC50
PARP
Bcl-2
Caspase
In Vitro
The effect of lucidenic acids (A, B, C, and N) isolated from a new G. lucidum (YK-02) on induction of cell apoptosis and the apoptotic pathway in HL-60 cells were investigated. The results demonstrated that lucidenic acids decreased cell population growth of HL-60 cells, assessed with the MTT assay. The cell cycle assay indicated that treatment of HL-60 cells with lucidenic acid A, C, and N caused cell cycle arrest in the G 1 phase. Lucidenic acid B (LAB) did not affect the cell cycle profile; however, it increased the number of early and late apoptotic cells but not necrotic cells. treatment of HL-60 cells with LAB caused loss of mitochondria membrane potential. Moreover, the ratio of expression levels of pro- and antiapoptotic Bcl-2 family members was changed by LAB treatment, LAB-induced apoptosis involved release of mitochondria cytochrome c and subsequently induced the activation of caspase-9 and caspase-3, which were followed by cleavage of poly(ADP-ribose) polymerase (PARP)[1]

Product References and Citations for Lucidenic acid B, inhibitor

Lucidenic acid B induces apoptosis in human leukemia cells via a mitochondria-mediated pathway.J Agric Food Chem. 2008 Jun 11;56(11):3973-80.
Lucidenic acid B induces apoptosis in human leukemia cells via a mitochondria-mediated pathway.J Agric Food Chem. 2008 Jun 11;56(11):3973-80.
The anti-invasive effect of lucidenic acids isolated from a new Ganoderma lucidum strain.Mol Nutr Food Res. 2007 Dec;51(12):1472-7.
Triterpene antioxidants from ganoderma lucidum.Phytother Res. 1999 Sep;13(6):529-31.

Other Notes

Small volumes of Lucidenic acid B, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Lucidenic acid B purchase

MBS5760599 is an inhibitor targeting Lucidenic acid B.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000